A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles

NCT03945513 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1034

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: LPRI424 (dienogest/ethinylestradiol)

Sponsor

Insud Pharma

Collaborators

[object Object]